List of Landos Biopharma patents

List of Landos Biopharma patents

List of Telular Corporation patents

List of Brunswick Corporation patents

List of Ascend Performance Materials patents

Founders educated at Motilal Nehru National Institute of Technology Allahabad

Companies in the Janitorial Services industry

Patents where

Current Assignee

Name

is

Landos Biopharma

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11377437 Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using same	Patent 11377437 was granted and assigned to Landos Biopharma on July, 2022 by the United States Patent and Trademark Office.	Landos Biopharma	Landos Biopharma		United States Patent and Trademark Office	11377437	July 5, 2022
	‌ US Patent 10493072 Lanthionine synthetase C-like 2-based therapeutics	Patent 10493072 was granted and assigned to Landos Biopharma on December, 2019 by the United States Patent and Trademark Office.	Landos Biopharma	Landos Biopharma		United States Patent and Trademark Office	10493072	December 3, 2019
	‌ US Patent 11066364 NLRX1 ligands	Patent 11066364 was granted and assigned to Landos Biopharma on July, 2021 by the United States Patent and Trademark Office.	Landos Biopharma	Landos Biopharma		United States Patent and Trademark Office	11066364	July 20, 2021
	‌ US Patent 10682349 Lanthionine synthetase C-like 2-based therapeutics		Landos Biopharma	Landos Biopharma		United States Patent and Trademark Office	10682349	June 16, 2020
	‌ US Patent 9839635 Lanthionine synthetase C-like 2-based therapeutics	Patent 9839635 was granted and assigned to Landos Biopharma on December, 2017 by the United States Patent and Trademark Office.	Landos Biopharma	Landos Biopharma		United States Patent and Trademark Office	9839635	December 12, 2017
	‌ US Patent 10849895 Lanthionine synthetase C-like 2-based therapeutics	Patent 10849895 was granted and assigned to Landos Biopharma on December, 2020 by the United States Patent and Trademark Office.	Landos Biopharma	Landos Biopharma		United States Patent and Trademark Office	10849895	December 1, 2020
	‌ US Patent 10028950 Lanthionine synthetase C-like 2-based therapeutics	Patent 10028950 was granted and assigned to Landos Biopharma on July, 2018 by the United States Patent and Trademark Office.	Landos Biopharma	Landos Biopharma		United States Patent and Trademark Office	10028950	July 24, 2018
	‌ US Patent 10487057 NLRX1 ligands	Patent 10487057 was granted and assigned to Landos Biopharma on November, 2019 by the United States Patent and Trademark Office.	Landos Biopharma	Landos Biopharma		United States Patent and Trademark Office	10487057	November 26, 2019
	‌ US Patent 10201538 Lanthionine synthetase C-like 2-based therapeutics	Patent 10201538 was granted and assigned to Landos Biopharma on February, 2019 by the United States Patent and Trademark Office.	Landos Biopharma	Landos Biopharma		United States Patent and Trademark Office	10201538	February 12, 2019
	‌ US Patent 11117881 Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same	Patent 11117881 was granted and assigned to Landos Biopharma on September, 2021 by the United States Patent and Trademark Office.	Landos Biopharma	Landos Biopharma		United States Patent and Trademark Office	11117881	September 14, 2021
	‌ US Patent 11197891 Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith	Patent 11197891 was granted and assigned to Landos Biopharma on December, 2021 by the United States Patent and Trademark Office.	Landos Biopharma	Landos Biopharma		United States Patent and Trademark Office	11197891	December 14, 2021
	‌ US Patent 10676436 NLRX1 ligands		Landos Biopharma	Landos Biopharma		United States Patent and Trademark Office	10676436	June 9, 2020

12 results

0 selected

12 results

0 selected